Last update at 2025-07-14T15:35:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
UK Dividend Stocks To Consider For Your Portfolio
Thu 22 May 25, 06:31 AM3 UK Dividend Stocks To Consider With Up To 6.5% Yield
Tue 20 May 25, 06:32 AMTop 3 UK Dividend Stocks For Your Portfolio
Mon 19 May 25, 06:32 AM3 UK Dividend Stocks To Watch With Up To 5.1% Yield
Thu 15 May 25, 06:31 AMUK Dividend Stocks Spotlight Featuring 3 Income Generators
Mon 12 May 25, 06:32 AM3 Dividend Stocks In The UK With Up To 7.1% Yield
Fri 09 May 25, 06:31 AMMay 2025's Leading UK Dividend Stocks
Thu 08 May 25, 06:31 AM3 UK Dividend Stocks Yielding Up To 5.3%
Fri 02 May 25, 06:31 AMTop UK Dividend Stocks To Consider In May 2025
Thu 01 May 25, 06:31 AMBreakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
Income before tax | 13.54M | 16.18M | 19.62M | 13.74M | 12.54M |
Minority interest | - | - | - | - | - |
Net income | 10.94M | 13.31M | 15.15M | 9.77M | 8.79M |
Selling general administrative | 29.16M | 23.31M | 20.88M | 16.78M | 15.16M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 44.82M | 39.08M | 42.22M | 31.88M | 28.66M |
Reconciled depreciation | 4.68M | 2.69M | 1.80M | 1.88M | 1.65M |
Ebit | 15.78M | 15.77M | 21.35M | 15.09M | 13.50M |
Ebitda | 20.45M | 18.47M | 23.16M | 17.04M | 15.07M |
Depreciation and amortization | 4.68M | 2.70M | 1.81M | 1.95M | 1.57M |
Non operating income net other | - | - | - | - | - |
Operating income | 14.52M | 15.77M | 21.35M | 15.09M | 13.50M |
Other operating expenses | 131.73M | 124.41M | 102.98M | 93.92M | 99.44M |
Interest expense | 1.09M | 0.53M | 0.44M | 0.40M | 0.34M |
Tax provision | 2.60M | 2.86M | 4.47M | 2.90M | 2.67M |
Interest income | 0.11M | 0.00800M | 0.01M | 0.07M | 0.14M |
Net interest income | -0.97700M | -0.51700M | -0.42700M | -0.33600M | -0.19900M |
Extraordinary items | - | - | - | -1.08000M | -1.08400M |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 2.60M | 2.86M | 4.47M | 2.90M | 2.67M |
Total revenue | 147.40M | 140.19M | 124.33M | 109.02M | 112.72M |
Total operating expenses | 29.16M | 23.31M | 20.88M | 16.78M | 15.38M |
Cost of revenue | 102.57M | 101.10M | 82.10M | 77.14M | 84.06M |
Total other income expense net | -0.97700M | 0.41M | -1.72900M | -1.35100M | -0.95400M |
Discontinued operations | - | - | - | -1.08000M | -1.08400M |
Net income from continuing ops | 10.94M | 13.31M | 15.15M | 10.85M | 9.87M |
Net income applicable to common shares | - | 13.31M | 15.15M | 9.77M | 8.79M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
Total assets | 175.02M | 188.18M | 149.42M | 123.52M | 129.89M |
Intangible assets | - | 3.21M | 2.42M | 1.36M | 0.84M |
Earning assets | - | - | - | - | - |
Other current assets | - | 37.83M | 29.08M | 25.68M | 24.17M |
Total liab | 37.77M | 54.33M | 43.12M | 32.40M | 42.78M |
Total stockholder equity | 137.25M | 133.85M | 106.30M | 91.12M | 87.11M |
Deferred long term liab | - | 0.89M | 0.58M | 0.43M | 0.14M |
Other current liab | 1.03M | 1.29M | 0.74M | 0.31M | 0.71M |
Common stock | 1.22M | 1.22M | 1.21M | 1.21M | 1.20M |
Capital stock | 1.22M | 1.22M | 1.21M | 1.21M | 1.20M |
Retained earnings | 105.12M | 96.08M | 80.08M | 62.76M | 56.74M |
Other liab | - | 5.37M | 8.98M | 12.33M | 9.51M |
Good will | - | - | - | - | - |
Other assets | - | 1.78M | 0.79M | 1.79M | 1.54M |
Cash | 0.81M | 2.35M | 7.26M | 7.74M | 37.19M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 32.55M | 46.33M | 30.56M | 15.99M | 28.91M |
Current deferred revenue | - | - | - | - | - |
Net debt | 10.38M | 22.42M | 9.11M | -0.42700M | -15.95800M |
Short term debt | 10.82M | 22.14M | 12.79M | 3.23M | 16.86M |
Short long term debt | 10.64M | 22.04M | 12.70M | 3.20M | 16.86M |
Short long term debt total | 11.19M | 24.77M | 16.37M | 7.31M | 21.23M |
Other stockholder equity | 30.90M | 36.55M | 25.01M | 27.16M | 29.16M |
Property plant equipment | - | 74.66M | 62.59M | 51.33M | 29.48M |
Total current assets | 96.48M | 108.54M | 83.61M | 69.47M | 98.16M |
Long term investments | - | - | - | - | - |
Net tangible assets | - | 130.64M | 103.88M | 90.19M | 86.40M |
Short term investments | - | - | - | - | - |
Net receivables | 32.97M | 37.83M | 29.07M | 23.91M | 22.25M |
Long term debt | 0.00000M | 2.34M | 2.62M | 3.45M | 4.37M |
Inventory | 62.40M | 68.35M | 47.26M | 36.05M | 36.80M |
Accounts payable | 20.70M | 22.90M | 17.03M | 12.44M | 11.33M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | - | - | - | -9.16800M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | 1.21M | 1.20M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | -0.00400M | -0.00500M | -0.01500M |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 3.72M | 1.78M | 2.42M | - | 31.73M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 78.54M | 79.64M | 65.81M | 54.05M | 31.73M |
Capital lease obligations | 0.55M | 0.40M | 1.05M | 0.66M | - |
Long term debt total | - | - | - | - | - |
Breakdown | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
Investments | -4.15500M | -7.16900M | -14.36100M | -24.88300M | -9.39600M |
Change to liabilities | - | 4.36M | 4.48M | 1.51M | -3.61400M |
Total cashflows from investing activities | - | -7.16900M | -14.36100M | -24.88300M | -9.39600M |
Net borrowings | - | 8.97M | 4.32M | -0.72400M | 1.87M |
Total cash from financing activities | -12.50900M | 4.38M | 0.96M | -4.11100M | -1.00600M |
Change to operating activities | - | - | - | - | - |
Net income | 13.54M | 16.18M | 19.62M | 12.58M | 11.48M |
Change in cash | 4.63M | -4.06700M | -5.00300M | -15.82600M | 8.02M |
Begin period cash flow | -3.82000M | 0.25M | 5.25M | 21.08M | 13.06M |
End period cash flow | 0.81M | -3.82000M | 0.25M | 5.25M | 21.08M |
Total cash from operating activities | 21.49M | -1.38700M | 8.57M | 13.49M | 18.34M |
Issuance of capital stock | 0.63M | 0.63M | 0.63M | 0.55M | 0.54M |
Depreciation | 4.68M | 2.69M | 1.80M | 1.88M | 1.65M |
Other cashflows from investing activities | - | 0.00800M | 0.01M | -0.06900M | 1.17M |
Dividends paid | 4.80M | 4.83M | 3.70M | 3.38M | 3.08M |
Change to inventory | 2.51M | -14.39600M | -11.85100M | -0.45800M | 3.97M |
Change to account receivables | - | -8.50200M | -2.68000M | -1.27800M | 5.29M |
Sale purchase of stock | - | - | 0.63M | 0.55M | 0.54M |
Other cashflows from financing activities | 9.40M | 8.94M | 4.71M | -1.28200M | 1.53M |
Change to netincome | - | 1.15M | 1.67M | 2.06M | 2.47M |
Capital expenditures | 5.71M | 12.77M | 14.37M | 24.81M | 10.57M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | 3.46M | -18.54300M | -10.04800M | -0.22500M | 5.65M |
Stock based compensation | 1.22M | 1.04M | 1.73M | 0.89M | 0.64M |
Other non cash items | 1.09M | -2.75300M | 0.27M | 0.19M | 0.20M |
Free cash flow | 15.78M | -14.16100M | -5.80500M | -11.32800M | 7.77M |
Sector: Basic Materials Industry: Specialty Chemicals
Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
TET Treatt PLC |
1.50 0.60% | 251.50 | 27.78 | 19.88 | 1.99 | 2.13 | 2.06 | 15.97 |
CRDA Croda International PLC |
-25.0 0.84% | 2953.00 | 36.36 | 24.75 | 3.83 | 3.08 | 4.05 | 18.15 |
JMAT Johnson Matthey PLC |
-8.0 0.43% | 1857.00 | 17.60 | 9.99 | 0.22 | 1.29 | 0.29 | 7.58 |
VCT Victrex plc |
-6.0 0.83% | 715.00 | 22.11 | 17.24 | 4.28 | 2.62 | 4.43 | 14.00 |
ELM Elementis PLC |
3.40 2.04% | 170.40 | - | 15.58 | 1.04 | 1.12 | 1.36 | 23.41 |
Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts and ingredients to the flavor, fragrance, beverage, and consumer product industries in the United Kingdom, Germany, Ireland, the United States, China, and internationally. The company offers flavor ingredients, such as citrus, coffee, tea, health and wellness, and fruits and vegetables extracts; Hics, aroma, and herb, spice, and floral ingredients. It also provides fragrance ingredients, such as blends and ingredients. The company was founded in 1886 and is based in Bury Saint Edmunds, the United Kingdom.
Skyliner Way, Bury Saint Edmunds, United Kingdom, IP32 7FR
Name | Title | Year Born |
---|---|---|
Mr. Daemmon Reeve | CEO & Exec. Director | NA |
Mr. Ryan Govender | Company Sec., CFO & Exec. Director | NA |
Mr. Kevin Butler | VP of Operations | NA |
Helen Pizzie | Global Technology Officer | NA |
Anita Guernari | Group Legal Counsel | NA |
Mr. Douglas Rash | VP of Global Sales & Marketing | NA |
Ms. Joanna Mapston | Global Head of HR | NA |
Wolfgang Tosch | Chief Innovation Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.